Analysis of Medical Costs of Type 2 Diabetes Mellitus Outpatient Muhammadiyah Hospital North Sumatra
DOI:
https://doi.org/10.18196/jmmr.v12i2.77Keywords:
Medical Cost, Type 2 Diabetes Mellitus, OutpatientAbstract
Type 2 diabetes mellitus and its complications are expensive. Complications are major cost drivers. Of the ten most outpatient diagnoses at Muhammadiyah Hospital, North Sumatra, there was a negative difference between INA-CBGs rates and hospital rates for type 2 diabetes mellitus cases. This study aims to estimate the medical cost, assess the average cost difference, and examine the cost component associated with outpatient type 2 diabetes mellitus. This quantitative analytic research used secondary data on outpatient medical records of type 2 diabetes mellitus patients from May 2019-April 2020. There were 61 samples of medical records. Results showed that the average annual medical cost of outpatient type 2 diabetes mellitus without complication was IDR. 298,177, 8 and IDR. 853,696,7, IDR. 932,341,7, IDR. 938,433.3 if accompanied by macrovascular complications, microvascular complications, and both, respectively. There was a significant difference (p = 0.004) in the mean medical costs per year between the complication groups. Drug costs significantly differed (p = 0.010) between the complication groups. Drug costs are the most expensive and are strongly associated with the medical costs of complicated type 2 diabetes mellitus.
References
Amalia, A., Andayani, T. M., & Yuniarti, E. (2015). HUBUNGAN KOMPLIKASI DIABETES MELITUS TERHADAP BIAYA TERAPI. JURNAL MANAJEMEN DAN PELAYANAN FARMASI (Journal of Management and Pharmacy Practice), 5(3), 159–170. https://doi.org/10.22146/jmpf.227
Abror, N. A., Andayani, T. M., & Sulistiawaty, E. (2019). Analisis biaya penyakit Diabetes Melitus sebagai pertimbangan perencanaan pembiayaan kesehatan. Jurnal Farmasi Galenika (Galenika Journal of Pharmacy)(e-Journal), 5(1), 73–83. https://doi.org/10.22487/j24428744.2019.v5.i1.12071
Baroroh, F., Solikah, W., & Urfiyya, Q. (2016). Analisis biaya terapi Diabetes Melitus tipe 2 Di Rumah Sakit Pku Muhammadiyah Bantul Yogyakarta. Jurnal Farmasi Sains dan Praktis, 1(2), 11-22. https://doi.org/10.31603/pharmacy.v1i2.230
Bommer, C., Heesemann, E., Sagalova, V., Manne-Goehler, J., Atun, R., Barnighausen, T., et al. (2017). The Global Economic Burden of Diabetes in Adult Aged 20-79: A Cost of Illness Study. The lancet Diabetes & endocrinology, 5(6), 423–430. https://doi.org/10.1016/S2213-8587(17)30097-9
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., et al. (2018). IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes research and clinical practice, 138, 271–281.
Cortez, D. N., Reis, I. A., Souza, D. A. S., Macedo, M. M. L., & Torres, H. D. C. (2015). Complications and the time of diagnosis of diabetes mellitus in primary care. Acta Paulista de Enfermagem, 28, 250–255. https://doi.org/10.1590/1982-0194201500042
Domeikienė, A., Vaivadaitė, J., Ivanauskienė, R., & Padaiga, Ž. (2014). Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina, 50(1), 54–60. https://doi.org/10.1016/j.medici.2014.05.007
Huebschmann, A. G., Huxley, R. R., Kohrt, W. M., Zeitler, P., Regensteiner, J. G., & Reusch, J. E. (2019). Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia, 62, 1761–1772. https://doi.org/10.1007/s00125-019-4939-5
Lathifah, R., Ghofir, A., Chalidyanto, D., & Yustiawan, T. (2018). Number and Type of Complications in Type 2 Diabetes Correlated with Outpatient Treatment Cost Using BPJS Self-Funded Scheme in Islamic Hospital Jombang. Science and Technology Publications, 290–294.
Mursalin, M., & Soewondo, P. (2017). Analisis Estimasi Biaya Langsung Medis Penderita Rawat Jalan Diabetes Mellitus Tipe 2 di RSUD Dr. Abdul Aziz Singkawang Tahun 2013. Jurnal Ekonomi Kesehatan Indonesia, 1(2). https://doi.org/10.7454/eki.v1i2.1770
Nathanson, D., Sabale, U., Erikson, J., Nystro , T., Norhammar, A., Olsson , U., et al. (2014). Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014. PharmacoEconomics - Open, 2(4), 393–402. https://doi.org/10.1007/s41669-017-0063-y
Zhuo, X., Zhang, P., & Hoerger, T. J. (2013). Lifetime Direct Medical Costs of Treating Type 2 Diabetes and Diabetic Complications. American Journal of Preventive Medicine, 45(3), 253–261. https://doi.org/10.1016/j.amepre.2013.04.017
Downloads
Published
Issue
Section
License
Copyright (c) 2023 JMMR (Jurnal Medicoeticolegal dan Manajemen Rumah Sakit)
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
